Landos Biopharma Inc.

NASDAQ: LABP · Real-Time Price · USD
22.93
0.13 (0.57%)
At close: May 23, 2024, 10:00 PM

Landos Biopharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a 18M
Cost of Revenue
n/a 577K 196K
Gross Profit
n/a -577K 17.8M
Operating Income
-22.73M -40.56M -38.82M
Interest Income
n/a n/a 412K
Pretax Income
-21.93M -39.28M -38.42M
Net Income
-21.93M -37.99M -38.23M
Selling & General & Admin
10.73M 14.88M 15.25M
Research & Development
12M 25.68M 41.56M
Other Expenses
n/a 1.28M 394K
Operating Expenses
22.73M 40.56M 56.82M
Interest Expense
n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a
Cost & Expenses
22.73M 40.56M 56.82M
Income Tax Expense
n/a -1.28M -196K
Shares Outstanding (Basic)
6.28M 4.03M 4.03M
Shares Outstanding (Diluted)
6.28M 4.03M 4.03M
EPS (Basic)
-3.5 -9.44 -9.5
EPS (Diluted)
-3.5 -9.44 -9.5
EBITDA
-22.73M -40.56M -38.82M
EBIT
-22.73M -39.85M -38.82M
Depreciation & Amortization
44K 577K 196K